An article published on PubMed.gov, Dec. 2011, describes a 40-year old woman with Pompe Disease who successfully carried a healthy baby to term. She continued to receive enzyme replacement therapy (ERT) with alglucosidase alfa. There were no maternal complications and the child developed normally. One year after delivery the mother’s physical condition was similar as prior to her pregnancy.
advocacy awards Awareness Breakthrough therapy designation business CAP chaperone clinical trials CORD COVID-19 Emma Rooney ERT Extraordinary Measures Fabry FDA fundraising Gaucher gene therapy genetics getting treated grants Health Canada home infusions IND Int'l Pompe Day IPA law living with Pompe meetings Muscular Dystrophy Canada MyNormal newborn screening NIH Orphan Drug Framework Orphanet portraits preclinical pregnancy privacy Rare Disease Rare Disease Day research respite substrate reduction therapy video